Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients

Molecular Medicine Reports

Volumn 4, Issue 2, 2011, Pages 383-387

  Jeong, Hye Cheol ^a   Kim, Eun Kyung ^a   Lee, Ji Hyun ^a   Lee, Ji Min ^b   Nayoo, Han ^b   Kim, Jin Kyeoung ^b  

^a CHA University   (South Korea)

^b CHA University   (South Korea)

Author keywords

Blood; Let 7a; Microrna; Non small cell lung cancer

Indexed keywords

LET 7A MIRNA; MICRORNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; CANCER CELL CULTURE; CANCER PATIENT; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG FIBROBLAST; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; ROC CURVE;

EID: 79551697148     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.430     Document Type: Article

References (28)

1. Iorio MV and Croce CM: MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848-5856, 2009.
2. Ortholan C, Puissegur MP, Llie M, Barbry P, Mari B and Hofman P: MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr Med Chem 16: 1047-1061, 2009.
3. Lebanony D, Benjamin H, Gilad S, et al: Diagnostic assay based on has-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 27: 2030-2037, 2009.
4. Wu X, Piper-Hunter MG, Crawford, Nuovo GJ, Marsh CB, Otterson GA and Nana-Sinkam SP: MicroRNAs in the pathogenesis of lung cancer. J Thorac Oncol 4: 1028-1034, 2009.
5. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST and Ghoshal K: Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin induced apoptosis by miR-1. J Biol Chem 283: 33394-33405, 2008.
6. Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, Burny A and Sculier JP: Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J 33: 352-359, 2009.
7. Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, Nuovo G, Marsh CB and Nana-Sinkam SP: MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 373: 607-612, 2008.
8. Fei J, Lan F, Guo M, Li Y and Liu Y: Inhibitory effects of antimiRNA oligonucleotides (AMOs) on A549 cell growth. J Drug Target 16: 688-693, 2008.
9. Liang Y: An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Med Genomics 1: 61-76, 2008.
10. Markou A, Tsaroucha EG, Kaklamanis L, Al-Majed AA, Al-Shabanah OA and Elkashef HA: Prognostic value of mature microRNA-21 and microRNA-205 over-expression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 54: 1696-1704, 2008.
11. Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, Zeng Y, Miao R, Jin G, Ma H, Chen Y and Shen H: Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608, 2008. (Pubitemid 351949787)
12. Yu SL, Chen HY, Chang GC, et al: MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13: 48-57, 2008.
13. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T and Takahashi T: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004. (Pubitemid 38697282)
14. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM and Harris CC: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
15. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
16. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS and Harris AL: Detection of elevated levels of tumor-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675, 2008. (Pubitemid 351667616)
17. Ho AS, Huang X, Cao H, Christman-Skieller C, Bennewith K, Le QT and Koong AC: Circulating miR-210 as a novel hypoxia marker in pancreatic cancer. Transl Oncol 3: 109-113, 2010.
18. Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A and Anderson B: Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLos One 4: e6229, 2009.
19. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C and Shen H: Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small cell lung cancer. J Clin Oncol 28: 1721-1726, 2010.
20. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D and Slack FJ: The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67: 7713-7722, 2007. (Pubitemid 47281364)
21. Maes OC, Sarojini H and Wang E: Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J Cell Physiol 221: 109-119, 2009.
22. Thomson JM, Parker J, Perou CM and Hammond SM: A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1: 47-53, 2004.
23. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T and Hammond SM: Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Drv 20: 2202-2207, 2006.
24. Ibanez-Ventoso C, Yang M, Guo S, Robins H, Padgett RW and Driscoll M: Modulated microRNA expression during adult lifespan in Caenorhabditis elegans. Aging Cell 5: 235-246, 2006. (Pubitemid 43805613)
25. Araya J and Nishimura SL: Fibrogenic reactions in lung disease. Annu Rev Pathol 5: 77-98, 2010.
26. Boyerinas B, Park S, Hau A, Murmann AE and Peter ME: The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17: F19-F36, 2010.
27. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C and Shen H: Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small cell lung cancer. J Clin Oncol 28: 1721-1726, 2010.
28. Zhong M, Ma X, Sun C and Chen L: MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer. Chem Biol Interact 184: 431-438, 2010.